Literature DB >> 18358696

Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.

Jing Wu1, Yang Qin, Bo Li, Wen-zhi He, Zhi-lin Sun.   

Abstract

In this study, 39 human hepatocellular carcinoma (HCC) tissues and 7 normal adult liver tissues were screened for heterozygous polymorphisms in IGF2, H19, and the differentially methylated region of H19 (H19DMR) using PCR-RFLP and PCR sequencing. The imprinting of IGF2 and H19 was examined by RT-PCR-RFLP, while the methylation profile of H19DMR was detected by bisulfite sequencing from every informative sample. Of the informative HCC samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19. Interestingly, we found three methylation profiles for H19DMR in the informative HCC samples: hyper-, medium-, and hypomethylated profiles. Furthermore, the hypomethylated and hypermethylated profiles were immediately associated with aberrant imprinting of IGF2 and H19.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358696     DOI: 10.1016/j.ygeno.2008.01.007

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  20 in total

1.  Dynamic expression patterns of imprinted genes in human embryonic stem cells following prolonged passaging and differentiation.

Authors:  Xiuyun Mai; Qingyun Mai; Tao Li; Canquan Zhou
Journal:  J Assist Reprod Genet       Date:  2010-12-16       Impact factor: 3.412

2.  The long non-coding RNA H19 - a new player in hepatocellular carcinoma.

Authors:  Maximilian A Ardelt; Johanna Pachmayr
Journal:  Cell Stress       Date:  2017-10-01

3.  DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival.

Authors:  John M Luk; Julja Burchard; Chunsheng Zhang; Angela M Liu; Kwong F Wong; Felix H Shek; Nikki P Lee; Sheung Tat Fan; Ronnie T Poon; Irena Ivanovska; Ulrike Philippar; Michele A Cleary; Carolyn A Buser; Peter M Shaw; Chuen-Neng Lee; Daniel G Tenen; Hongyue Dai; Mao Mao
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

Review 4.  Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

Authors:  Mónica Enguita-Germán; Puri Fortes
Journal:  World J Hepatol       Date:  2014-10-27

Review 5.  Environmental Influences on Genomic Imprinting.

Authors:  Maya Kappil; Luca Lambertini; Jia Chen
Journal:  Curr Environ Health Rep       Date:  2015-06

Review 6.  Targeting the insulin growth factor receptor 1.

Authors:  Fernanda I Arnaldez; Lee J Helman
Journal:  Hematol Oncol Clin North Am       Date:  2012-02-28       Impact factor: 3.722

7.  Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.

Authors:  Jun Lv; Ling Ma; Xi-Lin Chen; Xiao-Hui Huang; Qian Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

8.  Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.

Authors:  Sumadi Lukman Anwar; Till Krech; Britta Hasemeier; Elisa Schipper; Nora Schweitzer; Arndt Vogel; Hans Kreipe; Ulrich Lehmann
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

9.  Relationship of porcine IGF2 imprinting status to DNA methylation at the H19 DMD and the IGF2 DMRs 1 and 2.

Authors:  Martin H Braunschweig; Marta Owczarek-Lipska; Nasikhat Stahlberger-Saitbekova
Journal:  BMC Genet       Date:  2011-05-17       Impact factor: 2.797

10.  Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus.

Authors:  Raffaella Nativio; Kerstin S Wendt; Yoko Ito; Joanna E Huddleston; Santiago Uribe-Lewis; Kathryn Woodfine; Christel Krueger; Wolf Reik; Jan-Michael Peters; Adele Murrell
Journal:  PLoS Genet       Date:  2009-11-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.